• Monday, Dec 06, 2021
  • Last Update : 01:15 am

US FDA advisers back Moderna Covid booster shots for older and high-risk people

  • Published at 09:59 am October 15th, 2021
A healthcare worker holds a vial of the Moderna Covid-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (Covid-19) pandemic in Manhattan in New York City, New York, US, January 29, 2021 Reuters

The booster would be administered to people at least six months after the initial two-shot inoculation

A panel of expert advisers to the US Food and Drug Administration unanimously voted on Thursday to recommend booster shots of Moderna Inc's Covid-19 vaccine for Americans aged 65 and older and those at high risk of severe illness or occupational exposure to the virus.

If the FDA signs off on Moderna's booster, the US Centers for Disease Control and Prevention will make specific recommendations on who should get the shots. CDC advisers are scheduled to meet next week.

The FDA's Vaccines and Related Biological Products Advisory Committee met on Thursday to consider the additional dose of the Moderna vaccine and will weigh whether to make a similar recommendation for Johnson & Johnson's vaccine on Friday. The vote to back Moderna's booster was 19-0.

"The data itself is not strong, but it is certainly going in the direction that is supportable of this vote," said Dr Patrick Moore of the University of Pittsburgh School of Medicine. Moore said he voted in favor of Moderna boosters based largely on a "gut feeling rather than truly serious data."

Moderna shares were up nearly 3% at $330.71 after the vote.

FDA staff in documents posted on Tuesday said data for Moderna's vaccine showed that the booster does increase protective antibodies.

Also Read - Study: Moderna or Pfizer booster dose works better for people vaccinated with J&J vaccine

But they also said the difference in antibody levels before and after the shot was not wide enough by one measure of success specified by the FDA, particularly in those whose antibody levels had remained high.

Moderna is seeking authorization of a booster that contains 50 micrograms of vaccine, half of strength of its regular dose but still higher than the Pfizer-BioNTech shot using similar technology at 30 micrograms.

The booster would be administered to people at least six months after the initial two-shot inoculation.

US health officials have been under pressure to authorize Covid-19 vaccine booster doses after the White House announced in August it planned a widespread booster campaign pending approvals from the FDA and the CDC.

Both agencies signed off on Pfizer-BioNTech boosters for certain high-risk adults last month. Since then, nearly 9 million people have received a third shot, the CDC reported on Wednesday.

The panel heard presentations from Israeli health officials that boosters of the Pfizer/BioNTech vaccine helped curb the latest wave of infections in their country.

In the presentation on Thursday, they said the booster program in Israel improved severe disease protection in people aged 40 and older.

"What we're seeing is a break in the epidemic curve in Israel," said Dr Sharon Alroy-Preis, director of public health services at the Ministry of Health in Israel.

She said the booster program, which now includes 50% of the population among all age groups, is starting to reduce infections even among the unvaccinated in Israel.

Dr Ofer Levy, a vaccine expert at Boston Children's Hospital and a panel member, noted that the United States and Israel are different populations and that the vaccine Israel used is different although similar to the Moderna shot.

Dr Hayley Gans, a Stanford University Medical Center pediatrician and panel member, asked whether Israel's health ministry could tell how much of the country's waning Delta wave was attributable to the booster program and how much might have occurred without them.

"There is no question in my mind" that booster shots were responsible for the change in Israel's epidemic curve, Alroy-Preis responded.

In the United States, the Delta surge already has been begun to ease, with the seven-day average of daily Covid-19 cases falling 12% from the previous week, and the seven-day average of daily deaths down 5%. That is still more than 1,250 Covid-19 deaths a day, however, primarily among the unvaccinated.

Facebook 58
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail